Reaction
Lung Adenocarcinoma Metastatic reporting signals
As of the last recalculation, Lung Adenocarcinoma Metastatic appears in 233 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is ERLOTINIB HYDROCHLORIDE (PRR 82.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Erlotinib Hydrochloride | 11 | 82.4 | 82.4 |
| Crizotinib | 11 | 81.1 | 81.1 |
| Erlotinib | 6 | 56.8 | 56.8 |
| Pemetrexed Disodium | 19 | 48.4 | 48.4 |
| Pemetrexed | 8 | 34.5 | 34.5 |